Fractyl Health (GUTS) Net Margin (2023 - 2024)
Fractyl Health (GUTS) recorded quarterly Net Margin of 832333.33% in Q4 2024, down 402.86% on a QoQ basis from 165521.43% in Q3 2024, and down 49647619.0% YoY from N/an in Q1 2024.
Powered by 
Analysis
Fractyl Health (GUTS) Net Margin (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has reported Net Margin for 2 consecutive years, with 832333.33% the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Net Margin fell 49647619.0% year-over-year to 832333.33%; the trailing twelve-month figure through Dec 2024 stood at 75732.26% (up 282691.0% YoY), and the FY2024 full-year result was 75732.26%, up 282691.0% from the prior year.
- Net Margin was 832333.33% for Q4 2024 at Fractyl Health, down from 165521.43% in the prior quarter.
- The five-year high for Net Margin was 15330.3% in Q1 2024, with the low at 832333.33% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 13.47% |
| 10 | Fractyl Health | 102.41 Mn | 102.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -832,333.33% |
| Sep 30, 2024 | -165,521.43% |
| Jun 30, 2024 | -40,067.44% |
| Mar 31, 2024 | -15,330.30% |
| Dec 31, 2023 | -335,857.14% |
| Sep 30, 2023 | -55,772.22% |
| Jun 30, 2023 | -47,937.50% |
| Mar 31, 2023 | -323,360.00% |